Status: Currently enrolling
ClinicalTrials.gov Identifier: NCT01782989
TOGA: A randomized, double masked, placebo controlled study evaluating ORACEA in subjects with Geographic Atrophy secondary to Non-Exudative Age-related Macular Degeneration.
Condition: Geographic Atrophy
Study Type: Interventional
Duration: 30 months
Eligibility:
For additional information on this study, please click here
Back to Clinical Research